Advanced Biomedical Technology awarded Taiwan Government Grant (FY2019-2020)

Advanced Biomedical Technology Inc. has received two grants from the Ministry of Science and Technology (MOST) this year.   2019 Biomedical Leap Projects for Cross-industry Integration and 2019 R&D and innovation-based Industry-academia Collaboration Projects are most important and prospective government science project in Taiwan for all company which based in Science Park.

From these two projects, ABT Inc. is going to collaborate with plastic & reconstructive surgery department to define and discover the potential treatment strategy and benefits for microtia patients by using ABTs medical 3D printing total solution.

ABTs novel AM system aims at providing a next-generation total solution for medical 3D printing application. said Dr. Bruce Chen, CEO of ABT.   Additive manufacturing is becoming an ideal way to help surgeons get curve fitting and complex structure implant. It could save time to process the traditional implant before the surgery, especially for the implant will affect the appearance shape of patients. The government grant could help us collaborate with doctors and find out the best way to link customization service with the hospital.

Advanced Biomedical Technology Inc. (ABT Inc.) is a start-up located in Hsinchu Science Park who specialized in developing medical-grade material and service for medical 3D printing applications. Focus on providing realizable different medical grade 3D printing material and one-stop shop medical implant printing service to clients.

Advanced Biomedical Technology Inc., the first company in Taiwan, receives the FDA-announced Device Master File registering for biodegradable 3D-printing materials.

Advanced Biomedical Technology Inc., the first company in Taiwan, receives the FDA-announced Device Master File registering for biodegradable 3D-printing materials.

Advanced Biomedical Technology Inc. receives Device Master File (MAF) acknowledgment letter from FDA of the MeDFila® PCL-Ceramic 3D printing filament.

Advanced Biomedical Technology Inc. has successfully submitted a Device Master File to the Center for Devices and Radiological Health (CDRH) at the FDA for MeDFila®, their additive manufacturing (AM) PCL-Ceramic printing filament and received an Acknowledgment letter from the FDA confirming submission filing. For the medical device manufacturer, this MAF is now available for reference and review at the FDA.

“This MAF brings the MeDFila® another step closer to becoming the material of choice for medical 3D printing application and custom personal implant,” said Dr. Bruce Chen, CEO. “We will continue to deliver different composite material for medical 3D printing, which is a huge and growing market.”

Advanced Biomedical Technology Inc. shall provide MAF authorization letter on customer requests for their FDA’s review in the context of their product registration.

MeDFila® PCL series MAF status:

MAF Ready:

MeDFila® PCL-Ceramic (70%:30%) ; MAF Ready

Under FDA review process, MAF coming soon.

MeDFila® PCL ; MAF soon

MeDFila® PCL-Ceramic (50%:50%) ; MAF soon

MeDFila® PCL-Ceramic (60%:40%) ; MAF soon

For more information about MeDFila®

Please contact us for further information.

Workshop | Application of biodegradable medical-grade filaments

Our CEO Bruce Chen was invited to give a talk about the application of biodegradable 3DP material for orthopedic implant at Shanghai Ninth People’s Hospital, Shanghai JiaoTong University Schools of Medicine in China.

Shanghai Ninth People’s Hospital is a leading hospital which provides 3D printing medical service to patients. In the meeting, Bruce shared his professional experience and accomplishments in biomaterial and demonstrate the potential application of medical-grade 3D printing filament “MeDFila” for the orthopedic implant. To know more about MeDFila, please visit: MeDFila

合影留念

Material getting involv more in 3D printing

The world leading chemical company head into AM field with a strategic partner. It’s shown the great and bright future with AM integration with raw materials supplier. And we both find the image processing and materials property are synergized for better application. See the news”Optimizing materials and software for 3D printing

As a medical-grade 3D printing material provider, we believe this kind of cooperation will become more and more important, especially in medical application territory.

To see medical-grade material MeDFila.

banner-01 (1)

New office for Advanced Biomedical Technology Inc, in Hsinchu Science Park

Advanced Biomedical Technology Inc, (ABT) announced that its office in Hsinchu Biomedical Park, which was first opened in 2016, has now relocated to a larger facility in the Hsinchu Science Park.

圖片 1 (2)
The new headquarters office of Advanced Biomedical Technology in Hsinchu, Taiwan

Bruce Chen, CEO of ABT said “As a medical grade biodegradable material and biomedical additive manufacturing (AM) solution provider, we keep ahead and show our long-term commitment to provide high-quality biodegradable materials for additive manufacturing in the medical field. This facility combines our R&D and most advanced production plant, could provide our customers not only a single product but also a one-stop shop medical device development and manufacturing service with our own AM solution in the future.”

He continues, “In the past year, we made a great leap. Now we keep moving on to the next step to provide high-quality medical grade filaments to our customers and to discover more AM application in the medical field with our partner and customers.”

Contact details for the new office:

Advanced Biomedical Technology, Inc.
3F., No.22, Zhanye 2nd Rd., East Dist.,

Hsinchu City 300, Taiwan

Tel:   +886 3 6686948
Fax:   +886 3 6686894
E-mail: info@advbiomedtech.com

About Advanced Biomedical Technology, Inc.

Advanced biomedical technology (ABT) is a start-up who focusing on developing biodegradable material for 3D printing and 3D printing medical implant. ABT provides high-quality medical-grade biodegradable filaments for additive manufacturing application. In addition, ABT provides design, development and manufacturing service of medical implants to our customer.